İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2023

Serum Levels of IL-21, IL-23 and 8-hydroxy-2′-deoxyguanosine in Pediatric Severe Pneumonia Cases

Harran Üniversitesi Tıp Fakültesi Dergisi

YÖKSİS OpenAlex Açık erişim · diamond SJR Q2 JCR Q4 Atıf 0 Yüzdelik 23.6% FWCI 0.0
Yıl
2023
ISSN
1452-8258
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

Background: Pneumonia causes the majority of acute respiratory distress syndrome (ARDS) cases. The microbes that cause pneumonia are very diverse. In addition to DNA, RNA viruses, Gram-negative and Gram-positive bacteria cause two types of cytokine imbalances, anti-inflammatory and pro-inflammatory. It can also influence the progno-sis of sepsis and other infectious diseases. This study aims to search for 8-hydroxy-2'-deoxyguanosine (8-OHdG), IL-21, IL-23, and c-reactive protein (CRP) and compare cytokine levels. It is also to determine if Pediatric pneumonia patients CRP and cytokine levels correlate with results. Materials and Methods: In the study, blood was drawn from approximately 43 pediatric pneumonia patients and 43 healthy controls who came to the pediatric clinic to investigate serum IL-21, IL-23, 8-OHdG, and CRP levels. The levels of biomarkers were determined by ELISA method. Serum CRP levels were measured using the ATELLICA IM Analyzer. Results: Serum CRP, 8-OHdG, IL-21 and IL-23 levels were significantly higher in the pediatric pneumonia patient group than in the control group. Conclusions: Increased serum IL-21, IL-23, 8-OHdG and CRP expression in pediatric pneumonia patients is a poten-tial determinant suggesting that IL-21, IL-23-related cytokines may play a role in endothelial cell activation reported in patients. Increased 8-OHdG oxidative stress is more pronounced in patients without pediatric pneumonia while pro inflammatory cytokines are higher in pediatric pneumonia patients. However, it is used as a possible therapeu-tic target to reduce inflammation. Further study on the impact of these findings on comorbidities with larger num-ber test size is needed

Konular

  • Pediatric health and respiratory diseases
  • Inflammation biomarkers and pathways
  • COVID-19 Clinical Research Studies

Birincil konu Pediatric health and respiratory diseases

Yazarlar

  1. NİHAYET BAYRAKTAR HARRAN ÜNİVERSİTESİ
  2. AHMET GÜZELÇİÇEK HARRAN ÜNİVERSİTESİ
  3. ALİ ÖZTÜRK NİĞDE ÖMER HALİSDEMİR ÜNİVERSİTESİ
  4. MEHMET BAYRAKTAR
  5. HAMZA ERDOĞDU